Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia.
Bruno S, Bandini L, Patuelli A, Robustelli V, Venturi C, Mancini M, Forte D, De Santis S, Monaldi C, Grassi A, Chiurumbolo G, Paolini S, Cristiano G, Papayannidis C, Sartor C, Nanni J, Ottaviani E, Curti A, Cavo M, Soverini S. Bruno S, et al. Among authors: bandini l. Front Oncol. 2021 Sep 30;11:728613. doi: 10.3389/fonc.2021.728613. eCollection 2021. Front Oncol. 2021. PMID: 34660293 Free PMC article.
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia.
Bruno S, Bochicchio MT, Franchini E, Padella A, Marconi G, Ghelli Luserna di Rorà A, Venturi C, Raffini M, Prisinzano G, Ferrari A, Bandini L, Robustelli V, Pazzaglia M, Fontana MC, Sartor C, Abbenante MC, Papayannidis C, Soverini S, Ottaviani E, Simonetti G, Martinelli G. Bruno S, et al. Among authors: bandini l. J Oncol. 2019 Oct 30;2019:5985923. doi: 10.1155/2019/5985923. eCollection 2019. J Oncol. 2019. PMID: 31827512 Free PMC article.
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.
Papayannidis C, Nanni J, Cristiano G, Marconi G, Sartor C, Parisi S, Zannoni L, Saed R, Ottaviani E, Bandini L, Testoni N, Baldazzi C, Solli V, Ricci P, Di Giovanni Bezzi C, Abd-Alatif R, Stanzani M, Paolini S, Cavo M, Curti A. Papayannidis C, et al. Among authors: bandini l. Eur J Haematol. 2022 Jun;108(6):449-459. doi: 10.1111/ejh.13753. Epub 2022 Feb 28. Eur J Haematol. 2022. PMID: 35156731 Free PMC article.
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
Corradi G, Bassani B, Simonetti G, Sangaletti S, Vadakekolathu J, Fontana MC, Pazzaglia M, Gulino A, Tripodo C, Cristiano G, Bandini L, Ottaviani E, Ocadlikova D, Piccioli M, Martinelli G, Colombo MP, Rutella S, Cavo M, Ciciarello M, Curti A. Corradi G, et al. Among authors: bandini l. Clin Cancer Res. 2022 Jul 15;28(14):3141-3155. doi: 10.1158/1078-0432.CCR-21-3594. Clin Cancer Res. 2022. PMID: 35349670
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study.
Marconi G, Candoni A, Di Nicola R, Sartor C, Parisi S, Abbenante M, Nanni J, Cristiano G, Zannoni L, Lazzarotto D, Giannini B, Baldazzi C, Bandini L, Ottaviani E, Testoni N, Bezzi CDG, Abd-Alatif R, Ciotti G, Fanin R, Martinelli G, Paolini S, Ricci P, Cavo M, Papayannidis C, Curti A. Marconi G, et al. Among authors: bandini l. Cancer Med. 2023 May;12(10):11838-11848. doi: 10.1002/cam4.5858. Epub 2023 Mar 31. Cancer Med. 2023. PMID: 36999931 Free PMC article.
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure.
Sartor C, Brunetti L, Audisio E, Cignetti A, Zannoni L, Cristiano G, Nanni J, Ciruolo R, Zingarelli F, Ottaviani E, Patuelli A, Bandini L, Forte D, Sciabolacci S, Cardinali V, Papayannidis C, Cavo M, Martelli MP, Curti A. Sartor C, et al. Among authors: bandini l. Br J Haematol. 2023 Aug;202(3):599-607. doi: 10.1111/bjh.18887. Epub 2023 May 24. Br J Haematol. 2023. PMID: 37226312
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells.
Corradi G, Forte D, Cristiano G, Polimeno A, Ciciarello M, Salvestrini V, Bandini L, Robustelli V, Ottaviani E, Cavo M, Ocadlikova D, Curti A. Corradi G, et al. Among authors: bandini l. Front Immunol. 2024 May 15;15:1386517. doi: 10.3389/fimmu.2024.1386517. eCollection 2024. Front Immunol. 2024. PMID: 38812504 Free PMC article.
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets.
Bruno S, Borsi E, Patuelli A, Bandini L, Mancini M, Forte D, Nanni J, Barone M, Grassi A, Cristiano G, Venturi C, Robustelli V, Atzeni G, Mosca C, De Santis S, Monaldi C, Poletti A, Terragna C, Curti A, Cavo M, Soverini S, Ottaviani E. Bruno S, et al. Among authors: bandini l. Int J Mol Sci. 2024 Sep 17;25(18):10002. doi: 10.3390/ijms251810002. Int J Mol Sci. 2024. PMID: 39337490 Free PMC article.
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.
Bochicchio MT, Marconi G, Baldazzi C, Bandini L, Ruggieri F, Lucchesi A, Agostinelli C, Sabattini E, Orsatti A, Ferrari A, Capirossi G, Servili C, Ghelli Luserna di Rorà A, Martinelli G, Simonetti G, Rosti G. Bochicchio MT, et al. Among authors: bandini l. Int J Mol Sci. 2023 Dec 21;25(1):118. doi: 10.3390/ijms25010118. Int J Mol Sci. 2023. PMID: 38203288 Free PMC article.
Predictive equation derived from 6,497 doubly labelled water measurements enables the detection of erroneous self-reported energy intake.
Bajunaid R, Niu C, Hambly C, Liu Z, Yamada Y, Aleman-Mateo H, Anderson LJ, Arab L, Baddou I, Bandini L, Bedu-Addo K, Blaak EE, Bouten CVC, Brage S, Buchowski MS, Butte NF, Camps SGJA, Casper R, Close GL, Cooper JA, Cooper R, Das SK, Davies PSW, Dabare P, Dugas LR, Eaton S, Ekelund U, Entringer S, Forrester T, Fudge BW, Gillingham M, Goris AH, Gurven M, El Hamdouchi A, Haisma HH, Hoffman D, Hoos MB, Hu S, Joonas N, Joosen AM, Katzmarzyk P, Kimura M, Kraus WE, Kriengsinyos W, Kuriyan R, Kushner RF, Lambert EV, Lanerolle P, Larsson CL, Leonard WR, Lessan N, Löf M, Martin CK, Matsiko E, Medin AC, Morehen JC, Morton JP, Must A, Neuhouser ML, Nicklas TA, Nyström CD, Ojiambo RM, Pietiläinen KH, Pitsiladis YP, Plange-Rhule J, Plasqui G, Prentice RL, Racette SB, Raichlen DA, Ravussin E, Redman LM, Reilly JJ, Reynolds R, Roberts SB, Samaranayakem D, Sardinha LB, Silva AM, Sjödin AM, Stamatiou M, Stice E, Urlacher SS, Van Etten LM, van Mil EGAH, Wilson G, Yanovski JA, Yoshida T, Zhang X, Murphy-Alford AJ, Sinha S, Loechl CU, Luke AH, Pontzer H, Rood J, Sagayama H, Schoeller DA, Westerterp KR, Wong WW, Speakman JR. Bajunaid R, et al. Among authors: bandini l. Nat Food. 2025 Jan 13. doi: 10.1038/s43016-024-01089-5. Online ahead of print. Nat Food. 2025. PMID: 39806218
163 results